Updated Jul 16, 2026 · Last SEC filing 2026-07-01
Revolution Medicines, Inc. (RVMD) has filed 19 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-01. 3 Form 8-K material event filings were reported by RVMD in the last 90 days. 12 Form 144 notices of proposed sale were filed for RVMD stock. InsiderAlpha tracks every RVMD SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Biological Products, (No Diagnostic Substances) (SIC 2836) |
|---|---|
| SEC CIK | 0001628171 |
| Form 4 filings (90d) | 19 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 12 |
| Latest Form 4 filing | 2026-07-01 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Patel Sushil | Insider | S — Open-market sale | 600 | $190.54 | $114K | SEC | |
| Patel Sushil | Insider | S — Open-market sale | 100 | $188.57 | $19K | SEC | |
| Patel Sushil | Insider | S — Open-market sale | 881 | $192.61 | $170K | SEC | |
| Patel Sushil | Insider | M — Option exercise | 3.0K | $37.54 | $111K | SEC | |
| Patel Sushil | Insider | S — Open-market sale | 541 | $191.87 | $104K | SEC | |
| Patel Sushil | Insider | S — Open-market sale | 300 | $183.17 | $55K | SEC | |
| Patel Sushil | Insider | S — Open-market sale | 900 | $184.59 | $166K | SEC | |
| Patel Sushil | Insider | S — Open-market sale | 300 | $187.83 | $56K | SEC | |
| Patel Sushil | Insider | S — Open-market sale | 858 | $186.92 | $160K | SEC | |
| Patel Sushil | Insider | S — Open-market sale | 1.1K | $185.90 | $204K | SEC | |
| Anders Jack | Chief Financial Officer | S — Open-market sale | 4.6K | $167.34 | $762K | SEC | |
| Anders Jack | Chief Financial Officer | S — Open-market sale | 9.5K | $168.20 | $1.60M | SEC | |
| Anders Jack | Chief Financial Officer | S — Open-market sale | 5.7K | $169.24 | $956K | SEC | |
| Anders Jack | Chief Financial Officer | S — Open-market sale | 300 | $170.32 | $51K | SEC | |
| Anders Jack | Chief Financial Officer | M — Option exercise | 20.0K | $18.56 | $371K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Revolution Medicines, Inc. (RVMD). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Horn Margaret A | 24 | $19.63M |
| Patel Sushil | 13 | $1.16M |
| Mancini Anthony | 11 | $1.82M |
| Anders Jack | 7 | $4.16M |
| GOLDSMITH MARK A | 6 | $20.13M |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in RVMD insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live RVMD dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.